Neuroblastoma: Current Imaging and Therapeutics

Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 3

Abstract

Neuroblastoma is the most common solid abdominal tumor in children under the age of 2 years and accounts for approximately 15% of childhood mortality due to cancer. Its clinical behavior can vary from spontaneous regression to rapid fatal progression and anywhere in between (e.g. differentiation into benign tumors). Unfortunately, 50% of patients already have metastases at presentation. This marked clinical variability and often advanced presentation at time of diagnosis must be addressed with improved imaging and new treatments, particularly through focus on expanded drug development. Current treatment regimens (surgical resection, chemotherapy, and radiotherapy) have proven to be inadequate for treating advanced disease and frequently cause severe side effects that make them intolerable for many children. Promising new therapies include anti-adhesion therapy and immunotherapy, which uses antibodies to trigger a patient’s own immune system to destroy neuroblastoma cells. Of particular interest in the realm of anti-adhesion is attenuation of NF-κB over-activation. Increased NF-κB activity is thought to play a role in the development of tumor resistance to chemotherapeutic agents and radiation. Therefore, novel drugs to attenuate NF-kB activity could revolutionize treatment by increasing overall treatment effectiveness and allowing for reduced drug and radiation doses for dose-sensitive patients.

Authors and Affiliations

Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai

Keywords

Related Articles

Analysis of Orthopedic Surgery for Long Bone Metastases and Pathologic Fractures

The study made a retrospective analysis of treatment outcomes in 105 patients subjected to 128 surgical interventions for metastatic involvement of long tubular bones. Endoprosthetic replacement of large joints (40.2%) a...

Role of Breast Feeding and Parity in Prevalence of Breast Cancer and Bone Metastasis

Our aim was to evaluate the role of breast feeding and parity (alive and abortion) in prevalence of breast cancer and secondary bone metastasis. For The study purpose 100 diagnosed females of breast cancer were selected....

Do pathologists thoroughly Evaluate the Greater Omentum Following Gastrectomy for Malignancy: an Audit Based on Histopathology Reports

Introduction: Milky spots in greater omentum are primary sites for seeding of exfoliated cells from intra-abdominal malignancies. Surgery is the mainstay of treatment of gastric adenocarcinoma and the greater omentum is...

Factors Contributing to Delayed Breast Cancer Presentation: A Prospective Study at Parirenyatwa Group of Hospitals, Harare, Zimbabwe 2010-2013

Background: Breast cancer is one of the most common female cancers in Zimbabwe. A considerable proportion of patients delay presentation, leading to high morbidity and mortality. Delay in presentation can either be provi...

Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Aims: Advanced Hepatocellular carcinoma (HCC) is a major health problem with limited treatment options. The Sorafenib monothearpy is the only efficacious systemic treatment agent showing a survival benefit in these patie...

Download PDF file
  • EP ID EP242956
  • DOI 10.9734/JCTI/2015/16165
  • Views 107
  • Downloads 0

How To Cite

Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai (2015). Neuroblastoma: Current Imaging and Therapeutics. Journal of Cancer and Tumor International, 2(3), 89-109. https://europub.co.uk/articles/-A-242956